France Bed Holdings Co., Ltd. (JP:7840)
:7840
Want to see JP:7840 full AI Analyst Report?
Top Page
France Bed Holdings Co., Ltd.
(7840)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥1,382.00
▲(3.44% Upside)
Action:Downgraded
Date:05/18/26
The score is driven primarily by solid underlying financial performance (growth and gross profitability with manageable leverage) tempered by weakening margins and a weaker free-cash-flow profile. Valuation is supportive with a moderate P/E and attractive dividend yield, while technical indicators point to weak-to-neutral near-term momentum.
Positive Factors
Steady revenue growth
Multi-year top-line growth from ¥52.4B to ¥61.8B shows durable demand across consumer and institutional channels. Consistent revenue expansion supports scale, production planning and long-term contract credibility with healthcare customers, improving predictability of core cash flows.
Negative Factors
Eroding operating and net margins
Declining EBITDA and net margins over multiple years signal structural cost pressure or adverse mix shifts. Lower operating profitability reduces retained earnings and the firm's ability to fund investments internally, making long-term earnings growth and dividend sustainability more challenging.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
Multi-year top-line growth from ¥52.4B to ¥61.8B shows durable demand across consumer and institutional channels. Consistent revenue expansion supports scale, production planning and long-term contract credibility with healthcare customers, improving predictability of core cash flows.
Read all positive factors
France Bed Holdings Co., Ltd. (7840) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥42.51B
Dividend Yield2.97%
Average Volume (3M)23.58K
Price to Earnings (P/E)15.0
Beta (1Y)0.49
Revenue Growth1.99%
EPS Growth-3.72%
CountryJP
Employees1,783
SectorConsumer Cyclical
Sector Strength84
IndustryFurnishings, Fixtures & Appliances
Share Statistics
EPS (TTM)80.48
Shares Outstanding34,747,500
10 Day Avg. Volume26,760
30 Day Avg. Volume23,583
Financial Highlights & Ratios
PEG Ratio-4.17
Price to Book (P/B)1.08
Price to Sales (P/S)0.70
P/FCF Ratio36.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
France Bed Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
France Bed Holdings Co.,Ltd., through its various subsidiaries, operates within the medical services, home furnishing, and health sectors throughout Japan. The company's broad activities include the production, procurement, rental, retail, and who...
How the Company Makes Money
null...
France Bed Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
70
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.11B | 61.77B | 60.56B | 59.15B | 58.58B | 54.40B |
| Gross Profit | 33.07B | 33.81B | 33.06B | 31.89B | 31.19B | 29.00B |
| EBITDA | 9.77B | 9.60B | 10.00B | 10.39B | 10.28B | 9.49B |
| Net Income | 2.77B | 2.75B | 2.95B | 3.13B | 2.70B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 67.98B | 67.75B | 70.89B | 68.58B | 64.68B | 64.30B |
| Cash, Cash Equivalents and Short-Term Investments | 15.20B | 14.86B | 17.22B | 16.70B | 12.86B | 11.28B |
| Total Debt | 12.84B | 17.20B | 17.21B | 18.32B | 14.34B | 15.39B |
| Total Liabilities | 29.32B | 27.58B | 30.28B | 30.36B | 26.55B | 26.75B |
| Stockholders Equity | 38.67B | 40.16B | 40.61B | 38.21B | 38.12B | 37.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.20B | 2.71B | 3.06B | 4.13B | -568.00M |
| Operating Cash Flow | 0.00 | 6.33B | 7.45B | 7.83B | 8.93B | 6.01B |
| Investing Cash Flow | 0.00 | -4.32B | -4.93B | -5.62B | -6.69B | -7.78B |
| Financing Cash Flow | 0.00 | -2.88B | -2.50B | 633.00M | -2.66B | 316.00M |
France Bed Holdings Co., Ltd. Technical Analysis
Negative
1336.00
Price Trends
1270.60
Negative
1289.37
Negative
1288.79
Negative
Market Momentum
-5.67
Negative
47.53
Neutral
64.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7840, the sentiment is Negative. The current price of 1336 is above the 20-day moving average (MA) of 1226.90, above the 50-day MA of 1270.60, and above the 200-day MA of 1288.79, indicating a neutral trend. The MACD of -5.67 indicates Negative momentum. The RSI at 47.53 is Neutral, neither overbought nor oversold. The STOCH value of 64.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7840.
France Bed Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
65 Neutral | ¥42.51B | 14.96 | ― | 2.97% | 1.99% | -3.72% | |
65 Neutral | ¥131.57B | 12.36 | ― | 2.20% | 12.74% | 24.57% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥3.32B | 6.87 | ― | 4.00% | 5.78% | 15.22% | |
43 Neutral | ¥8.01B | -5.48 | ― | 2.65% | 1.29% | -181.94% |
* Consumer Cyclical Sector Average
JP:7840
France Bed Holdings Co., Ltd.
1,230.00
5.73
0.47%
JP:7791
DREAMBED CO.,LTD.
805.00
63.41
8.55%
JP:7898
Wood One Co., Ltd.
858.00
57.63
7.20%
JP:7972
Itoki Corporation
2,486.00
461.68
22.81%
JP:7981
Takara Standard Co., Ltd
3,015.00
738.48
32.44%
JP:8130
Sangetsu Corporation
2,881.00
125.93
4.57%
France Bed Holdings Co., Ltd. Corporate Events
France Bed Posts Higher Sales but Lower Profit, Lifts Dividend and Projects Earnings Recovery
May 15, 2026
France Bed Holdings reported consolidated net sales of ¥61.77 billion for the year ended March 31, 2026, up 1.9% year on year, while operating profit fell 7.7% to ¥4.34 billion and profit attributable to owners of parent declined 6.8% to...
France Bed Sets FY2027 Earnings and Dividend Targets, Shifts Focus to Profitability
Mar 27, 2026
France Bed Holdings has announced its consolidated earnings and dividend forecast for the fiscal year ending March 31, 2027, targeting net sales of ¥63.4 billion, operating profit of ¥4.6 billion, and profit attributable to owners of par...
France Bed Lowers Full-Year Profit Outlook Despite Modest Sales Growth
Mar 4, 2026
France Bed Holdings reported consolidated net sales of ¥44.8 billion for the nine months ended December 31, 2025, up 1.4% year on year, but operating profit fell 5.5% to ¥3.09 billion and profit attributable to owners of parent declined ...
France Bed Sets 2026 Shareholder Perks and Plans Program Revision for 2027
Mar 4, 2026
France Bed Holdings has set the details of its shareholder benefit program for the fiscal year ending March 2026, targeting shareholders with at least 200 shares as of March 31, 2026, and offering product-based rewards to express appreciation and ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.